Michael K Leonard
Overview
Explore the profile of Michael K Leonard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
694
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Petteys M, Medaris L, Williamson J, Soman R, Denmeade T, Anderson W, et al.
Antimicrob Steward Healthc Epidemiol
. 2022 Oct;
2(1):e12.
PMID: 36310774
Antibiotic overuse is high in patients hospitalized with coronavirus disease 2019 (COVID-19) despite a low documented prevalence of bacterial infections in many studies. In this study evaluating 65 COVID-19 patients...
2.
Sampson M, Polk C, Fairman R, DeWitt M, Leonard M, Davidson L, et al.
Infect Control Hosp Epidemiol
. 2022 Sep;
44(2):348-349.
PMID: 36102128
No abstract available.
3.
Beavers S, Pascopella L, Davidow A, Mangan J, Hirsch-Moverman Y, Golub J, et al.
Ann Am Thorac Soc
. 2018 Mar;
15(6):683-692.
PMID: 29490150
More information on risk factors for death from tuberculosis in the United States could help reduce the tuberculosis mortality rate, which has remained steady for more than a decade. To...
4.
Leonard M, Blumberg H
Microbiol Spectr
. 2017 Apr;
5(2).
PMID: 28409551
Musculoskeletal tuberculosis (TB) accounts for approximately 10% of all extrapulmonary TB cases in the United States and is the third most common site of extrapulmonary TB after pleural and lymphatic...
5.
Lewinsohn D, Leonard M, LoBue P, Cohn D, Daley C, Desmond E, et al.
Clin Infect Dis
. 2017 Jan;
64(2):111-115.
PMID: 28052967
Background: Individuals infected with Mycobacterium tuberculosis (Mtb) may develop symptoms and signs of disease (tuberculosis disease) or may have no clinical evidence of disease (latent tuberculosis infection [LTBI]). Tuberculosis disease...
6.
Lewinsohn D, Leonard M, LoBue P, Cohn D, Daley C, Desmond E, et al.
Clin Infect Dis
. 2016 Dec;
64(2):e1-e33.
PMID: 27932390
Background: Individuals infected with Mycobacterium tuberculosis (Mtb) may develop symptoms and signs of disease (tuberculosis disease) or may have no clinical evidence of disease (latent tuberculosis infection [LTBI]). Tuberculosis disease...
7.
Adelman M, Kurbatova E, Wang Y, Leonard M, White N, McFarland D, et al.
PLoS One
. 2014 Jul;
9(7):e100649.
PMID: 25014783
Introduction: The Centers for Disease Control and Prevention has recommended using a nucleic acid amplification test (NAAT) for diagnosing pulmonary tuberculosis (TB) but there is a lack of data on...
8.
Leeds I, Magee M, Kurbatova E, Del Rio C, Blumberg H, Leonard M, et al.
Clin Infect Dis
. 2012 Mar;
55(1):75-81.
PMID: 22423123
Background: In the United States, the proportion of patients with extrapulmonary tuberculosis (EPTB) has increased relative to cases of pulmonary tuberculosis. Patients with central nervous system (CNS)/meningeal and disseminated EPTB...
9.
Tukvadze N, Kempker R, Kalandadze I, Kurbatova E, Leonard M, Apsindzelashvili R, et al.
PLoS One
. 2012 Feb;
7(2):e31563.
PMID: 22347495
Background: The WHO has recommended the implementation of rapid diagnostic tests to detect and help combat M/XDR tuberculosis (TB). There are limited data on the performance and impact of these...
10.
Schaffner J, Chochua S, Kourbatova E, Barragan M, Wang Y, Blumberg H, et al.
J Infect Dev Ctries
. 2009 Sep;
3(4):267-72.
PMID: 19759489
Background: The etiology and outcomes of blood-stream infections (BSI) among paediatric patients is not well described in resource-limited countries including Georgia. Methodology: Patients with positive blood cultures at the largest...